176 related articles for article (PubMed ID: 2902937)
1. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
Watt B; Naden MG
Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
Watt B; Naden MG
J Chemother; 1989 Jul; 1(4 Suppl):106-7. PubMed ID: 16312326
[No Abstract] [Full Text] [Related]
3. [Activity of cefotetan against anaerobic bacteria].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of anaerobes to 8 antibiotics].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
7. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of cefotaxime on anaerobes (author's transl)].
Soussy CJ; Thibault M; Duval J
Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
van der Westhuyzen I; Chalkley LJ
S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.
Snydman DR; Jacobus NV; McDermott LA
J Antimicrob Chemother; 2005 Jun; 55(6):1024-8. PubMed ID: 15824092
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
Aldridge KE; Stratton CW
J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to erythromycin of anaerobes of the genera Bacteroides, Fusobacterium, Sphaerophorus, Veillonella, Clostridium, Corynebacterium, Peptococcus, Peptostreptococcus.
Werner H; Boehm M; Kunstek-Santos H; Lohner C; Jordan T
Arzneimittelforschung; 1977; 27(12):2263-5. PubMed ID: 580038
[TBL] [Abstract][Full Text] [Related]
17. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
Aldridge KE; Johnson WD
J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180
[TBL] [Abstract][Full Text] [Related]
18. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
Goldstein EJ; Citron DM
J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
Freydière AM; Gille Y; Marcel JP; Vincent P
Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
Wüst J; Hardegger U
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
